Men, women and HIV

March 19, 2001

Injection drug use has been recognized as one of the major routes of HIV transmission. However, in a cohort of injection drug users in Montreal, Julie Bruneau and colleagues determined sex-related differences in risk behaviour could have implications for the development of preventive and clinical interventions.

The authors report that needle-sharing with a person known to be HIV positive (odds ratio [OR] for men 2.44, 95% CI 1.29-7.13) and needle-sharing in the past 6 months (OR for men 0.61, 95% CI 0.44-0.85; OR for women 0.32, 95% CI 0.14-0.73) were independently associated with HIV infection. Among men, sexual orientation, preference for cocaine over heroin, frequency of injection drug use, and obtaining needless at a pharmacy or through a needle exchange program were major risk factors. Among women, other variables were obtaining needles at shooting galleries and failing to participate in a treatment program.

In a related commentary, Patricia Spittal and Martin Schechter tell one woman's story to illustrate how issues such as physical abuse, commercial sex work, drug use, vulnerability and despair can result in HIV infection.
-end-
Sex-specific determinants of HIV
infection among injection drug users in Montreal
-- J. Bruneau et al
Contact: Dr. Eduardo Franco, Department of Epidemiology and Biostatistics, McGill University, Montreal; tel 514 398-6032

Injection drug use through the lens of gender
-- P.M. Spittal, M.T. Schechter
Contact: Dr. Martin Schechter, Department of Epidemiology, University of British
Columbia, Vancouver; tel 604 822-3910

Canadian Medical Association Journal

Related HIV Infection Articles from Brightsurf:

Scientists pinpoint new mechanism that impacts HIV infection
A team of scientists led by Texas Biomed's Assistant Professor Smita Kulkarni, Ph.D. and Mary Carrington, Ph.D., at the Frederick National Laboratory for Cancer Research, published results of a study that pinpointed a long noncoding RNA molecule which influences a key receptor involved in HIV infection and progression of the disease.

HIV: Reprogramming cells to control infection
Following research on cohorts, scientists from the Institut Pasteur have described the characteristics of CD8 immune cells in these 'HIV controller' subjects.

USPSTF recommendation on screening for HIV infection
The US Preventive Services Task Force (USPSTF) recommends screening for HIV infection in adolescents and adults ages 15 to 65; in those younger or older at increased risk of infection; and in all pregnant people.

HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.

HIV vaccine protects non-human primates from infection
New research shows that an experimental HIV vaccine strategy works in non-human primates.

New guidelines for treatment and prevention of HIV infection in adults
Experts have updated recommendations for the use of antiretroviral drugs in the treatment and prevention of HIV infection.

Updated recommendations for treating, preventing HIV infection
A volunteer panel of experts in HIV research and patient care evaluated new data and treatments to update recommendations from the International Antiviral Society-USA for the use of antiretroviral drugs in this special communication article.

Tracking down T cell targets to tamp down HIV infection
Scientists have narrowed in on a group of gut-residing immune cells that might predispose women to increased HIV infection risk and more severe disease.

Two antibodies are better than one for preventing HIV infection
A cocktail of two broadly-neutralizing HIV-1 antibodies (bNAbs) protected primates against infection with a mixed population of HIV viruses -- conditions that mimic real-world transmission -- researchers report.

Novel approach to track HIV infection
Scientists used a novel live-cell fluorescent imaging system that allowed them for the first time to identify individual viral particles associated with HIV infection.

Read More: HIV Infection News and HIV Infection Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.